New Antiepileptic Drugs
NEJM 334:1583-1590, Dichter,M.A.&Brodie,M.J., 1996
The Use of Parenteral Antiepileptic Drugs & The Role of Fosphenytoin
(Suppl Editor) , Neurol 46:S1-S2896., Wilder,B.J., 1996
Treatment of Advanced Parkinson's Disease by Posterior GPi Pallidotomy:1-Year Results of a Pilot Study
Ann Neurol 40:355-366, 3411996., Baron,M.S.,et al, 1996
Alzheimer Disease and Nonfluent Progressive Aphasia
Arch Neurol 53:1072-1078, Greene,J.D.W.,et al, 1996
Cognitive and Brain Magnetic Resonance Imaging Findings in Adrenomyeloneuropathy
Ann Neurol 40:675-678, Edwin,D.,et al, 1996
Clinicopath Conf
Intravascular Lymphomatosis Involving Brain & Other Organs, Case 30-1996, NEJM 335:952-9596., , 1996
Incorrect Diagnosis of Alzheimer's Disease:A Clinicopathologic Study
Arch Neurol 53:35-42, Klatka,L.A.,et al, 1996
Subjective Memory Complaints May Announce Dementia
Neurol 46:121-125, Schmand,B.,et al, 1996
A Man with Weight Loss, Ataxia, and Confusion for 3 Months
Lancet 347:448, Beversdorf,D.,et al, 1996
Accuracy and Reliability of Periodic Sharp Wave Complexes in Creutzfeldt-Jakob Disease
Arch Neurol 53:162-166, Steinhoff,B.J.,et al, 1996
Estrogen Replacement Therapy and Risk of Alzheimer Disease
Arch Int Med 156:2213-2217, Paganinni-Hill,A.&Henderson,V.W., 1996
Increased Writing Activity in Neurological Conditions:A Review and Clinical Study
JNNP 61:510-514, vanVugt,P.,et al, 1996
Apolipoprotein E Phenotype Freq & CSF Concentra are not Assoc with Creutzfeldt-Jakob Disease
Arch Neurol 53:1233-1238, Zerr,I.,et al, 1996
The Babinski Sign:100 Years On
BMJ 313:1029-1030, Ditunno,J.F.&Bell,R., 1996
Assessment of Brain SPECT:Report of the Therapeutics and Technology Assessment Subcommittee of the AAN
Neurol 46:278-285, , 1996
Diagnosis of Creutzfeldt-Jakob Disease in Two-Dimensional Gel Electrophoresis of Cerebrospinal Fluid
Lancet 348:846-849, Zerr,I.,et al, 1996
Cerebral Syphilitic Gumma in an HIV-Negative Patient Presenting as Prolonged Focal Motor Status Epilepticus
NEJM 335:1159-1160, Suzrez,J.I.,et al, 1996
Diagnostic Guidelines in Central Nervous System Whipple's Disease
Ann Neurol 40:561-568, Louis,E.D.,et al, 1996
Whipple Disease Confined to the Central Nervous System in Childhood
AJNR 17:1589-1591, Duprez,T.P.J.,et al, 1996
Acute Low Back Pain:A New Paradigm for Management
BMJ 313:1343-1344, Deyo,R.A., 1996
New Antiepileptic Drugs:A Systematic Review of Their Efficacy and Tolerability
BMJ 313:1169-1174, 1157, 1158996., Marson,A.G.,et al, 1996
Visual Hallucinations Associated with Parkinson Disease
Arch Neurol 53:1265-1268, Sanchez-Ramos,J.R.,et al, 1996
Rapidly Progressive Dementia Caused by Nonenhancing Primary Lymphoma of the Central Nervous System
AJNR 17:1695-1697, Carlson,B.A., 1996
Psychiatric Features in Diffuse Lewy Body Disease:A Clinicopath Study Using Alzheimer's & PD Groups
Neurol 47:1148-1152, Klatka,L.A.,et al, 1996
Reversible Dementia and Apparent Brain Atrophy During Valproate Therapy
Ann Neurol 38:687-691, Papazian,O.,et al, 1995
A Low, "Normal"Score on the Mini-Mental State Exam Predicts Development of Dementia after Three Years
JAGS 43:656-661, Braekhus,A.,et al, 1995
MRI of Creutzfeldt-Jakob Disease:Asymmetric High Signal Intensity of the Basal Ganglia
Neurol 45:1932-1933, Yoon,S.S.,et al, 1995
Creutzfeldt-Jakob Disease and Bovine Spongiform Encephalopathy:Any Connection?
BMJ 311:1415-1421, Almond,J.W., 1995
Interventional Neuroradiology
BMJ 311:789-792, Taylor,W.&Rodesch,G., 1995
Regional Distrib of Neurofibrillary Tangles & Senile Plaques in Cerebral Cortex of Very Old Pts
Arch Neurol 52:1150-1159, Gioannakopoulos,P.,et al, 1995
Hereditary Leukoencephalopathy and Palmoplantar Keratoderma:A New Disorder with Increased Skin Collagen Content
Neurol 45:331-337, Lossos,A.,et al, 1995
Parkinsonism-Recognition and Differential Diagnosis
BMJ 310:447-452, Quinn,N., 1995
Sneddon's Syndrome is a Thrombotic Vasculopathy:Neuropathologic and Neuroradiologic Evidence
Neurol 45:557-560, Geschwind,D.H.,et al, 1995
Diagnosis and Evaluation of Dementia
Neurol 45:211-218, Corey-Bloom,J.,et al, 1995
Tacrine
Lancet 345:625-630, Davis,K.L.&Powchik,P., 1995
Synergistic Effects of Traumatic Head Injury and Apolipoprotein-E4 In Patients with Alzheimer's Disease
Neurol 45:555-557, Mayeux,R.,et al, 1995
Management of the Behavioral Manifestations of Dementia
Arch Int Med 155:250-260, Yeager,B.F.,et al, 1995
Clinical, Neuropath & Genetic Studies of Large Spinocerebellar Ataxia Type 1 (SCA1) Kindred: (CAG) n Early Premonitory Signs & Symp
Neurol 45:24-30, Genis,D.,et al, 1995
A Single-Photon Emission Computed Tomographic Study of Anosognosia in Alzheimer's Disease
Arch Neurol 52:415-420, Starkstein,S.E.,et al, 1995
Autosomal Dominant Migraine with MRI White-Matter Abnormalities Mapping to the CADASIL Locus
Neurol 45:1086-1091, Chabriat,H.,et al, 1995
Is Alzheimer's Disease an Apolipoprotein E Amyloidosis?
Lancet 345:956-958, Wisniewski,T.,et al, 1995
Clinical and Genetic Studies of Fatal Familial Insomnia
Neurol 45:1068-1075, Reder,A.T.,et al, 1995
Dentatorubral-Pallidoluysian Atrophy:Clin Features Closely Related to Unstable Expansion of Trinucleotide (CAG) Repeat
Ann Neurol 37:769-775, Ikeuchi,T.,et al, 1995
Apolipoprotein E Genotype in Diverse Neurodegenerative Disorders
Ann Neurol 38:131-135, Schneider,J.A.,et al, 1995
Down's Syndrome and the Links with Alzheimer's Disease
JNNP 59:111-114, Holland,A.J.&Oliver,C., 1995
Apolipoprotein E Genotyping in the Differential Diagnosis, Not Prediction, of Alzheimer's Disease
Ann Neurol 38:6-14, Roses,A.D., 1995
Apolipoprotein E Genotyping in the Diagnosis of Alzheimer's Disease:A Cautionary View
Ann Neurol 38:2-4, Bird,T.D., 1995
Effectiveness & Safety of Velnacrine for Treatment of Alzheimer's Disease:A Double Blind, Placebo-Controlled Study
Arch Int Med 155:1766-1772, Antuono,P.G.,et al, 1995
Age-Associated Memory Impairment:Sorting Out the Controversies
Neurol 45:611-614, 7411995., Larrabee,G.J.&McEntee,W.J., 1995
Dementia:The Failing Brain
Lancet 345:1481-1484, Cummings,J.L., 1995